查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2011569

医疗保健领域人工智慧市场：按组件、技术类型、部署方式、应用领域、最终用户和疾病类型划分——2026-2032年全球市场预测

Artificial Intelligence in Medicine Market by Component, Technology Type, Deployment Mode, Application Areas, End-User, Disease Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医疗领域的人工智慧 (AI) 市场价值将达到 156.2 亿美元，到 2026 年将成长到 193.5 亿美元，到 2032 年将达到 753.3 亿美元，复合年增长率为 25.20%。

主要市场统计数据
基准年 2025 156.2亿美元
预计年份：2026年 193.5亿美元
预测年份 2032 753.3亿美元
复合年增长率 (%) 25.20%

先进的计算智慧与临床专业知识的融合，正在推动以患者为中心的下一代医疗保健解决方案的发展。

人工智慧将复杂的运算模型与临床洞见结合，正引领医疗保健创新进入一个新时代。随着复杂演算法能够分析大量患者数据，它们正在重塑诊断流程，实现疾病的早期检测，并丰富医疗专业人员的决策流程。这种整合正在推动更广泛的变革，促使医院和研究中心探索如何利用人工智慧改善患者预后，同时满足日益增长的对经济高效且扩充性解决方案的需求。

随着人工智慧重新定义整体领域的诊断准确性、治疗通讯协定和营运效率，本文概述了模式转移的方向。

医疗产业正经历着翻天覆地的变革，人工智慧技术正提升病人历程的各个环节，并重塑我们诊断和治疗的方式。在放射学领域，智慧型影像分析平台正从实验性插件发展成为必不可少的决策工具，提高了异常检测的灵敏度，并缩短了读取时间。同时，自然语言处理正在革新临床文件记录方式，从非结构化病历中提取关键的患者信息，并助力急诊医学领域的即时决策。

评估关税调整对美国医疗保健生态系中医疗设备进口和发展趋势的溢出效应。

将于2025年实施的医疗设备和人工智慧硬体进口关税修订方案，正对美国医疗产业产生重大影响。影像系统、机器人手术平台和专用处理器关税的提高，迫使供应商重新评估其供应链策略，许多供应商选择将组装流程本地化，并与国内零件製造商建立长期伙伴关係。这种调整反过来又刺激了美国研发领域的投资，增强了边缘运算和专用人工智慧晶片设计等领域的能力。

根据组件、应用、技术采用和疾病类型，确定清晰的市场细分趋势，并指导策略定位。

对市场区隔的详细分析揭示了人工智慧投资最为集中的领域以及新机会所在。从组件角度来看，随着医疗系统寻求指南以应对复杂的部署流程，咨询、整合和实施服务等服务导向的产品正日益受到关注。同时，儘管针对特定临床功能的应用软体的采用率正在迅速增长，但底层系统软体平台也在不断发展，以支援扩充性的人工智慧工作负载。

确定影响北美、南美、欧洲、中东、非洲和亚太地区医疗保健环境中人工智慧采用趋势的区域特征。

区域差异对人工智慧的应用模式和投资重点有显着影响。例如，在美洲，成熟的医疗保健市场拥有健全的报销机制和完善的监管流程，正在加速人工智慧在影像中心和大规模医院网路中的应用。因此，该地区的医疗服务提供者能够大规模试行先进的决策支援工具，并持续改善其与现有电子健康记录系统的整合。

在竞争激烈的产业环境中，分析推动智慧医疗解决方案发展的关键创新者和策略伙伴关係。

领先的科技公司和专业医疗设备供应商正在建立合作伙伴关係，以扩大人工智慧的应用范围并加深其对临床实践的影响。大型云端服务供应商正与影像设备製造商合作，提供整合分析套件；而成熟的医疗设备原始设备製造商 (OEM) 则正在收购人工智慧软体Start-Ups，以增强其诊断产品组合。同时，科技巨头们正在投资开放式研究联盟，共同开发针对医疗保健应用场景最佳化的新型机器学习架构。

制定积极主动的蓝图，其中包括医疗保健和技术领导者可以采取的行动策略，以最大限度地利用人工智慧主导的临床和营运机会。

对于希望在医疗保健领域充分发挥人工智慧潜力的行业领导者而言，前瞻性的方法至关重要。首先，建立健全的资料管治框架，确保演算法基于高品质、具代表性的资料集进行训练，从而减少偏差并提高临床有效性。同时，组成由临床医生、资料科学家和监管专家组成的跨职能团队，可以加快引进週期并简化合规流程。

详细介绍结合一手和二手资讯的稳健混合研究框架，以确保全面的市场情报。

本研究整合了第一手资料和第二手资料，以确保提供全面均衡的市场视角。第一手资料收集包括对关键医疗保健利益相关者、技术供应商和监管相关人员进行结构化访谈，以直接了解采用障碍、投资重点和未来发展蓝图。除这些访谈外，还对临床医生和IT决策者进行了问卷调查，以了解他们对表现、易用性和长期价值的期望。

本研究整合了关键发现，揭示了人工智慧融入医疗保健生态系统的策略挑战和未来前景。

这项分析揭示了在医疗保健和人工智慧交叉领域运作的组织面临的几项策略挑战。首先，清楚了解服务和软体动态、特定技术能力、部署偏好以及疾病特异性优先事项，将有助于更精准地分配资源。其次，必须制定充分考虑区域法规环境和基础设施成熟度的打入市场策略，以优化部署路径并最大限度地减少摩擦。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：医疗领域的人工智慧市场：按组件划分

  • 服务
    • 咨询服务
    • 整合和实施服务
  • 软体
    • 应用软体
    • 系统软体

第九章：医疗领域的人工智慧市场：按技术类型划分

  • 电脑视觉
  • 机器学习
  • 自然语言处理
  • 机器人技术

第十章：医疗领域的人工智慧市场：依部署模式划分

  • 基于云端的
  • 现场

第十一章：按应用领域分類的医疗领域人工智慧市场

  • 诊断
    • 医学影像
    • 病理诊断
  • 药物发现
  • 治疗

第十二章：医疗领域的人工智慧市场：依最终用户划分

  • 医疗保健提供者
    • 诊所
    • 医院
  • 製药公司
  • 研究机构和学术机构

第十三章：医疗领域的人工智慧市场：依疾病类型划分

  • 循环系统
  • 皮肤科
  • 胃肠病学
  • 神经病学
  • 妇产科
  • 肿瘤学
  • 眼科
  • 整形外科
  • 儿童
  • 泌尿系统

第十四章：医疗领域的人工智慧市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：医疗领域的人工智慧市场：按类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：医疗领域的人工智慧市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国医疗保健产业的人工智慧市场

第十八章：中国医疗保健产业的人工智慧市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Aidoc Medical Ltd.
  • Allscripts Healthcare Solutions, Inc.
  • BenevolentAI Limited
  • Butterfly Network, Inc.
  • CloudMedx Inc.
  • Enlitic, Inc.
  • Epic Systems Corporation
  • Exscientia plc
  • Freenome Holdings, Inc.
  • GE Healthcare
  • Google LLC By Alphabet Inc.
  • HeartFlow, Inc.
  • IBM Corporation
  • Insilico Medicine, Inc.
  • Intel Corporation
  • Koninklijke Philips NV
  • Medtronic plc
  • NVIDIA Corporation
  • Owkin, Inc.
  • PathAI, Inc.
  • Qventus, Inc.
  • Recursion Pharmaceuticals, Inc.
  • Siemens Healthineers AG
  • Tempus Labs, Inc.
  • Viz.ai, Inc.
  • Zebra Medical Vision Ltd.
Product Code: MRR-4330CC794AA4

The Artificial Intelligence in Medicine Market was valued at USD 15.62 billion in 2025 and is projected to grow to USD 19.35 billion in 2026, with a CAGR of 25.20%, reaching USD 75.33 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.62 billion
Estimated Year [2026] USD 19.35 billion
Forecast Year [2032] USD 75.33 billion
CAGR (%) 25.20%

Unveiling the Convergence of Advanced Computational Intelligence and Clinical Expertise to Drive Next Generation Patient-Centric Medical Solutions

Artificial intelligence is ushering in a new era of medical innovation by merging advanced computational models with clinical acumen. As complex algorithms gain the ability to analyze vast quantities of patient data, they are redefining diagnostic pathways, enabling earlier detection of conditions, and enriching the decision-making process for healthcare professionals. This convergence has fueled a broader transformation, prompting hospitals and research centers alike to explore how AI can enhance patient outcomes while addressing the mounting demand for cost-effective, scalable solutions.

Over the past decade, breakthroughs in machine learning techniques such as convolutional neural networks and natural language processing have elevated the precision of medical imaging interpretation and automated the classification of pathological findings. Concurrently, integration with electronic health records has allowed clinicians to draw on predictive analytics that identify at-risk populations and anticipate resource needs. As a result, workflows are becoming more streamlined, with routine tasks increasingly handled by intelligent systems, freeing specialists to focus on complex clinical challenges.

Despite these advancements, significant barriers remain, including data privacy concerns, algorithmic bias, and the necessity for robust validation protocols. Bridging the gap between promising pilot studies and large-scale deployments requires rigorous testing, close collaboration between technology developers and medical practitioners, and alignment with evolving regulatory frameworks. Nevertheless, the current moment represents a watershed in which AI-driven tools are poised to move from experimental phases into everyday practice.

This executive summary provides a structured exploration of the forces reshaping the AI in medicine landscape, offering leaders a clear understanding of transformative shifts, segmentation insights, regional dynamics, corporate strategies, and actionable recommendations for sustained innovation and growth.

Charting the Paradigm Shift as Artificial Intelligence Redefines Diagnostic Accuracy Treatment Protocols and Operational Efficiency Across Healthcare

Healthcare is experiencing seismic shifts as AI-enabled technologies augment every stage of the patient journey, reshaping how diagnoses are made and treatments are administered. In radiology departments, intelligent image analysis platforms have transitioned from experimental add-ons to essential decision-support tools, delivering enhanced sensitivity in detecting anomalies and reducing interpretation times. Meanwhile, natural language processing is revolutionizing clinical documentation, extracting critical patient information from unstructured notes and enabling real-time decision-making in emergency care.

Beyond diagnostics, AI is transforming drug discovery by accelerating target identification and optimizing compound screening, heralding a shift from traditional trial-and-error approaches toward data-driven precision. Robotics augmented with machine vision have begun to assist surgeons with unprecedented dexterity, offering minimally invasive procedures that reduce patient recovery times. In parallel, telehealth services are embracing intelligent triage systems that guide virtual consultations and allocate resources according to urgency, ultimately improving access in underserved regions.

Operational efficiencies are also emerging as pivotal differentiators, with predictive maintenance algorithms ensuring that critical imaging and monitoring equipment remain online and reliable. Administrative overhead is diminishing as intelligent workflows automate claims processing and revenue cycle management. Altogether, these developments illustrate a comprehensive redefinition of care delivery models, moving toward a future in which continuous learning systems adapt to emerging clinical evidence and patient needs.

Assessing the Ripple Effects of Tariff Adjustments on Medical Device Importation and Development Dynamics within the United States Healthcare Ecosystem

The introduction of revised import tariffs for medical devices and AI-enabled hardware in 2025 is exerting notable influence on the United States healthcare industry. Increased duties on imaging systems, robotic surgical platforms, and specialized processors have led vendors to reassess supply chain strategies, with several opting to localize assembly operations and secure long-term partnerships with domestic component manufacturers. This repositioning has, in turn, spurred investment in U.S.-based research and development, bolstering capabilities in areas such as edge computing and specialized AI chip design.

Simultaneously, software providers that traditionally packaged AI solutions with imported appliances have restructured licensing agreements to decouple software from hardware, aiming to mitigate tariff impacts on end-users. Subscription-based models and cloud-hosted deployments are gaining traction, as these modalities bypass import classifications attributed to physical goods. However, organizations operating in high-acuity settings continue to weigh the trade-offs between on-premise control and cloud-based flexibility.

In addition, the anticipated cost pressures have galvanized collaborations between academic medical centers and domestic semiconductor firms to prototype next-generation AI accelerators tailored for healthcare workloads. These efforts are being reinforced by federal incentives designed to enhance critical technology manufacturing within national borders. Collectively, these shifts underscore a broader trend toward supply chain resilience and highlight the strategic importance of tariff-aware procurement planning as institutions invest in future-ready intelligence architectures.

Illuminating Distinct Market Segmentation Vectors by Component Application Technology Deployment and Disease Type to Guide Strategic Positioning

A nuanced understanding of market segments reveals where AI investments are most concentrated and where emerging opportunities lie. On the basis of component, service-oriented offerings such as consulting, integration, and deployment services are commanding attention as healthcare systems seek guidance navigating complex implementations. Concurrently, applications software tailored for specific clinical functions is experiencing robust uptake, while underlying system software platforms continue to evolve to support scalable AI workloads.

When considering technology type, computer vision engines are at the forefront of imaging diagnostics, yet machine learning frameworks remain indispensable for predictive analytics and patient risk stratification. Natural language processing modules are unlocking insights in clinical narratives and administrative documentation, whereas robotic systems-integrating haptic feedback and high-resolution imaging-are revolutionizing procedural accuracy.

Deployment preferences further shape adoption curves, with cloud-based solutions offering rapid scalability and reduced upfront investments, while on-premise implementations appeal to institutions with stringent data sovereignty and latency requirements. Across application areas, diagnostics spearhead early commercialization efforts, particularly in medical imaging and digital pathology detection, but drug discovery pipelines are increasingly leveraging deep learning to accelerate compound screening. In treatment settings, AI-driven decision support is guiding personalized therapy regimens.

End-users span from healthcare providers, both clinics and hospitals seeking operational efficiencies, to pharmaceutical companies optimizing research workflows, and academic centers advancing translational research. Finally, disease-specific platforms address cardiology, dermatology, gastroenterology, neurology, obstetrics and gynecology, oncology, ophthalmology, orthopedics, pediatrics, and urology, underscoring the breadth of AI applicability across medical specialties.

Unearthing the Regional Nuances Influencing AI Adoption Trends across the Americas Europe Middle East Africa and Asia-Pacific Healthcare Landscapes

Regional variations cast distinct influences on AI adoption patterns and investment priorities. In the Americas, for instance, mature healthcare markets are characterized by robust reimbursement frameworks and established regulatory pathways, accelerating deployments of AI in imaging centers and large hospital networks. As a result, providers in this region are able to pilot advanced decision-support tools at scale and refine integration with existing electronic health record systems.

Transitioning to Europe, the Middle East, and Africa, regulatory environments present both challenges and opportunities. Stricter data privacy regulations in parts of Europe have incentivized on-premise deployments and federated learning models, whereas emerging markets in the Middle East and Africa are exploring AI-powered telemedicine to address provider shortages. Collaborative initiatives between governments and private entities are fostering data-sharing consortia that underpin translational research.

Meanwhile, Asia-Pacific nations are demonstrating rapid growth in AI-driven healthcare as governments invest heavily in digital health infrastructure. Initiatives targeting universal health coverage are deploying intelligent triage and remote monitoring platforms, particularly in densely populated urban centers. Cross-border partnerships are also nurturing local talent development and the establishment of innovation hubs that bridge academia and industry. Taken together, these regional nuances highlight the need for tailored go-to-market strategies and regulatory navigation plans to optimize AI integration globally.

Profiling Leading Innovators and Strategic Partnerships Steering the Evolution of Intelligent Medical Solutions in a Competitive Industry Environment

Leading technology companies and specialized healthcare vendors are forging alliances to expand their AI footprints and deepen clinical impact. Major cloud service providers are collaborating with imaging device manufacturers to offer integrated analytics suites, while established medical equipment OEMs are acquiring AI software startups to enhance their diagnostic portfolios. In parallel, technology giants are investing in open research consortia to co-develop novel machine learning architectures optimized for medical use cases.

Strategic partnerships between pharmaceutical firms and AI platform developers are accelerating drug discovery and repurposing programs, leveraging predictive models to identify promising molecular targets and forecast patient responses. At the same time, academic health systems are entering licensing agreements with software vendors to commercialize algorithms validated in real-world clinical environments, closing the loop between research breakthroughs and market-ready solutions.

Smaller innovative players are differentiating through specialization, focusing on niche applications such as telepathology, robotic rehabilitation, or digital therapeutics. These companies frequently engage in pilot deployments with regional hospital networks, gathering data to refine performance and secure broader contracts. Across the competitive landscape, intellectual property portfolios and interoperability standards emerge as key differentiators, shaping which entities attract strategic investments and long-term collaborations.

Charting a Proactive Roadmap with Actionable Tactics for Healthcare and Technology Leaders to Capitalize on AI-Driven Clinical and Operational Opportunities

For industry leaders seeking to harness the full potential of AI in medical contexts, adopting a proactive stance is essential. Initially, establishing robust data governance frameworks will ensure that algorithms are trained on high-quality, representative datasets, mitigating bias and enhancing clinical validity. Concurrently, fostering cross-functional teams that bring together clinicians, data scientists, and regulatory experts will accelerate deployment cycles and streamline compliance processes.

Investment in workforce development is equally critical, as organizations must cultivate talent capable of translating complex algorithmic outputs into actionable clinical insights. Moreover, prioritizing interoperability through adherence to open standards will facilitate seamless integration with existing health IT systems, reducing implementation risk and accelerating time to value. Engaging early with regulatory agencies will clarify approval pathways and preempt compliance obstacles.

To further differentiate, leaders should pilot modular AI solutions in high-impact use cases-such as sepsis detection or automated radiology triage-and iterate based on user feedback. Simultaneously, incorporating cybersecurity safeguards will protect patient data and maintain stakeholder trust. Lastly, embedding ethical considerations throughout the development lifecycle, from algorithm design to user training, will establish a foundation for sustainable growth and societal acceptance.

Detailing a Robust Mixed-Method Research Framework Combining Primary Interviews and Secondary Data Sources to Ensure Comprehensive Market Intelligence

This research integrates both primary and secondary methodologies to ensure a comprehensive and balanced market perspective. Primary data collection involved structured interviews with executive stakeholders at leading healthcare institutions, technology vendors, and regulatory bodies, providing firsthand insights into adoption barriers, investment priorities, and future roadmaps. These conversations were complemented by surveys targeting clinicians and IT decision-makers, capturing expectations for performance, usability, and long-term value.

Secondary research included an extensive review of peer-reviewed journals, white papers, regulatory filings, and patent databases to contextualize technological maturity and identify emerging innovation clusters. Industry reports and conference proceedings were analyzed to trace partnership announcements, funding flows, and strategic alliances. Publicly available financial statements and corporate presentations furnished additional clarity around R&D spending and commercialization strategies.

Data triangulation techniques were employed to validate qualitative findings against quantitative indicators, ensuring consistency and mitigating bias. Expert panels convened at key project milestones reviewed preliminary conclusions and refined thematic frameworks. Throughout the research process, rigorous quality checks and version controls upheld methodological transparency and reproducibility.

Synthesizing Key Findings to Illuminate Strategic Imperatives and Future Prospects for Artificial Intelligence Integration in Medical Ecosystems

The collective insights gleaned from this analysis underscore several strategic imperatives for organizations operating at the intersection of healthcare and artificial intelligence. First, a clear understanding of service versus software dynamics, technology-specific capabilities, deployment preferences, and disease area priorities will enable more informed resource allocation. Second, regional regulatory environments and infrastructure maturity must inform market entry tactics to optimize adoption trajectories and minimize friction.

Corporate success will hinge on collaborative innovation models, pairing the agility of specialized AI startups with the domain expertise and scale of established healthcare and technology players. Furthermore, actionable roadmaps that balance rapid prototyping with rigorous validation will expedite time to clinical impact, delivering measurable improvements in patient outcomes and operational efficiencies. Leaders who invest in ecosystem partnerships, governance standards, and ethical guardrails will be best positioned to sustain long-term growth.

Looking ahead, emerging trends such as federated learning, multimodal AI, and personalized medicine promise to further transform care paradigms. Organizations that remain vigilant to evolving technological horizons and regulatory landscapes will unlock new value streams and shape the future of intelligent medical practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Intelligence in Medicine Market, by Component

  • 8.1. Services
    • 8.1.1. Consulting Services
    • 8.1.2. Integration & Deployment Services
  • 8.2. Software
    • 8.2.1. Applications Software
    • 8.2.2. System Software

9. Artificial Intelligence in Medicine Market, by Technology Type

  • 9.1. Computer Vision
  • 9.2. Machine Learning
  • 9.3. Natural Language Processing
  • 9.4. Robotics

10. Artificial Intelligence in Medicine Market, by Deployment Mode

  • 10.1. Cloud-Based
  • 10.2. On-Premise

11. Artificial Intelligence in Medicine Market, by Application Areas

  • 11.1. Diagnostics
    • 11.1.1. Medical Imaging
    • 11.1.2. Pathology Detection
  • 11.2. Drug Discovery
  • 11.3. Treatment

12. Artificial Intelligence in Medicine Market, by End-User

  • 12.1. Healthcare Providers
    • 12.1.1. Clinics
    • 12.1.2. Hospitals
  • 12.2. Pharmaceutical Companies
  • 12.3. Research Institutes & Academic Centers

13. Artificial Intelligence in Medicine Market, by Disease Type

  • 13.1. Cardiology
  • 13.2. Dermatology
  • 13.3. Gastroenterology
  • 13.4. Neurology
  • 13.5. Obstetrics & Gynecology
  • 13.6. Oncology
  • 13.7. Ophthalmology
  • 13.8. Orthopedics
  • 13.9. Pediatrics
  • 13.10. Urology

14. Artificial Intelligence in Medicine Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Artificial Intelligence in Medicine Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Artificial Intelligence in Medicine Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Artificial Intelligence in Medicine Market

18. China Artificial Intelligence in Medicine Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Aidoc Medical Ltd.
  • 19.6. Allscripts Healthcare Solutions, Inc.
  • 19.7. BenevolentAI Limited
  • 19.8. Butterfly Network, Inc.
  • 19.9. CloudMedx Inc.
  • 19.10. Enlitic, Inc.
  • 19.11. Epic Systems Corporation
  • 19.12. Exscientia plc
  • 19.13. Freenome Holdings, Inc.
  • 19.14. GE Healthcare
  • 19.15. Google LLC By Alphabet Inc.
  • 19.16. HeartFlow, Inc.
  • 19.17. IBM Corporation
  • 19.18. Insilico Medicine, Inc.
  • 19.19. Intel Corporation
  • 19.20. Koninklijke Philips N.V.
  • 19.21. Medtronic plc
  • 19.22. NVIDIA Corporation
  • 19.23. Owkin, Inc.
  • 19.24. PathAI, Inc.
  • 19.25. Qventus, Inc.
  • 19.26. Recursion Pharmaceuticals, Inc.
  • 19.27. Siemens Healthineers AG
  • 19.28. Tempus Labs, Inc.
  • 19.29. Viz.ai, Inc.
  • 19.30. Zebra Medical Vision Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY INTEGRATION & DEPLOYMENT SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY INTEGRATION & DEPLOYMENT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY INTEGRATION & DEPLOYMENT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATIONS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATIONS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATIONS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SYSTEM SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SYSTEM SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SYSTEM SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ROBOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ROBOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ROBOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATHOLOGY DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATHOLOGY DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATHOLOGY DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES & ACADEMIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES & ACADEMIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES & ACADEMIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DERMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 211. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 213. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 215. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 216. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 218. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 244. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 245. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 248. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 249. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 251. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 252. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 255. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 256. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 259. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 260. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 262. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)